Iran Talks Could Shake Oil Prices: 3 Stocks to Buy Now
Diplomacy with Iran could spark big moves in oil this week. If talks gain momentum, prices could ease; if they stall,...
Which Index Funds Are Best For Iras 2024
Understand which index funds are best for IRAs in 2024, with guidance on diversification, costs, and long-term retirement goals.
24,195 articles
Piper Sandler Hikes Cloudflare Target to $250 Amid Dip
Piper Sandler lifts Cloudflare’s target to $250 despite a double-digit after-hours fall, arguing the core growth stor...
Is First Majestic Silver After Latest Earnings a Buy?
Investors are weighing the latest earnings from First Majestic Silver. This article breaks down what the numbers mean...
Prediction: Trump Bull Market Could End Abruptly Soon
The stock market often rides policy signals as much as earnings. This piece digs into two decision scenarios that cou...
Goldman Sachs Says ASICs Could Overtake GPUs by 2027
A shift in AI hardware could redefine winners and losers in tech investing. Here’s how ASICs may outpace GPUs and whi...
Rivian Rallies as Tesla Stalls; NIO Slips on Rally Maneuvers and R2 Growth
Rivian shares jumped about 8% amid a crucial R2 production debut and rising software revenue, even as peers Tesla and...
BingEx (FLX) 2025 Earnings: What Investors Should Know
BingEx FLX is navigating a pivotal year. This article breaks down the Q4 2025 earnings, explains the key metrics, and...
Beyond Meat's Pivot Protein: Does It Alter the Thesis?
Beyond Meat is shifting from plant-based meat to protein drinks. This article explores whether beyond meat's pivot pr...
Adobe (ADBE) 2026 Earnings: Outlook, Risks, and Strategy
Adobe's 2026 earnings trajectory hinges on subscription momentum, AI-enabled products, and disciplined costs. This gu...
Defi’s Next Institutional Wave Emerges From Users Unaware
A wave of institutional money into DeFi may ride through the front ends users touch every day, not via on-chain walle...
Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Better Obesity Drug Race: Novo Nordisk vs Lilly 2026
In the race to dominate obesity drugs, Novo Nordisk and Eli Lilly are frontrunners. This guide analyzes who has the e...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status